Perspective Therapeutics, Inc. (CATX)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 1.8400 |
| Open | 1.8300 |
| Bid | 0.0000 x 4000 |
| Ask | 1.8000 x 1100 |
| Day's range | 1.7000 - 1.8500 |
| 52-week range | 0.2100 - 1.9000 |
| Volume | |
| Avg. volume | 4,394,695 |
| Market cap | 1.033B |
| Beta (5Y monthly) | 1.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Lantheus Holdings Inc (LNTH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
Impressive quarterly performance with significant revenue growth and strategic advancements in radiopharmaceuticals.
- GuruFocus.com
Perspective Therapeutics Inc (CATX) Reports Fiscal Year 2023 Financial Results
Significant R&D Investments Lead to Increased Losses Despite Revenue Gains from Grants
- Zacks
PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth
PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.